CareCloud, Inc. (CCLD)

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Plan Based on Growing Recurring Revenues and Margins; Double Dividends Expected to Continue until Series B Dividend Arrears are Fully Satisfied SOMERSET, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”) today announced that its Board of Directors has adopted a formal plan (the “Plan”) to satisfy the 14 months of accumulated and unpaid dividends (i.e.

CareCloud, Inc. ( CCLD ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Kristen Rothe Stephen Snyder - Co-Chief Executive Officer Hadi Chaudhry Norman Roth - Assistant Corporate Secretary, CFO, Principal Accounting Officer & Controller Mahmud Haq - Founder & Executive Chairman Conference Call Participants Allen Klee - Maxim Group LLC, Research Division Michael Kim - Zacks Small-Cap Research Presentation Operator Greetings, and welcome to the CareCloud, Inc. Third Quarter 2025 Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.

Raises Revenue Guidance, Completes Medsphere Acquisition and Accelerates AI Initiative SOMERSET, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions, today announced strong financial results for the quarter ended September 30, 2025, and is increasing its full-year 2025 revenue guidance to $117 – $119 million, up from the initial range of $111 – $114 million.

Company to highlight AI innovation, strategic acquisitions, and continued growth momentum SOMERSET, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology solutions, announced today its participation in the ThinkEquity Conference, taking place October 30, 2025, at the Mandarin Oriental, New York City.

CareCloud Inc. Series B Preferred Shares are not traditional fixed-income instruments but a high-risk bet on the company's survival. CCLD recently converted Series A preferred shares to common stock, reducing dividend obligations and improving its net income outlook. CCLDO experienced an -85% drawdown in 2023/2024, showing high volatility and strong correlation with CCLD common shares, unlike typical preferreds.

SOMERSET, N.J., Oct. 07, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (“CareCloud” or the “Company”) (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its Board of Directors (the “Board”) has declared monthly cash dividends for its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock (“Series A Preferred Stock”) and its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (“Series B Preferred Stock”) for October, November and December 2025.

Acquisition and long-term partnership with HFMA further strengthen CareCloud's position in the inpatient healthcare IT market SOMERSET, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-driven healthcare technology solutions for hospitals, integrated health systems, and medical practices nationwide, today announced its definitive agreement to acquire MAP App, a leading hospital benchmarking tool created by the Healthcare Financial Management Association (“HFMA”).

Platform strengthens physician alignment and referral management; live presentation scheduled for October 8 SOMERSET, N.J., Sept. 25, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and AI-powered solutions, today unveiled Marketware, its hospital-focused physician relationship management and analytics platform, which it added to its portfolio as part of its recent Medsphere acquisition.

CareCloud secures a $10M Provident Bank credit facility to fund the $16.5M Medsphere acquisition, replacing a costlier Wells Fargo note. The Medsphere deal aligns with CCLD's strategy to expand into the hospital market and leverage AI-driven solutions for revenue growth and operational efficiency. Management upgrades 2025 revenue guidance to $116–$118M and projects $128–$130M in 2026, citing Medsphere integration and cross-selling opportunities.

Transformational acquisition extends CareCloud's reach into inpatient EHR and RCM, bringing affordable solutions to small and mid-sized hospitals nationwide. SOMERSET, N.J.

CareCloud, Inc. (NASDAQ:CCLD ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants A. Hadi Chaudhry - Co-CEO & Director Hadi Chaudhry - Corporate Participant Mahmud U.

Delivers first quarter of positive GAAP EPS in Company's history since going public, announces initial results from AI Initiative SOMERSET, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and generative AI solutions, today announced strong financial results for the quarter ended June 30, 2025.

SOMERSET, N.J., Aug. 04, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leading provider of healthcare technology and generative AI solutions, today announced that its electronic health record (“EHR”) platform has achieved ONC Health IT Certification specifically for Critical Access Hospitals (“CAHs”), a milestone officially granted on August 1, 2025.

SOMERSET, N.J., July 25, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its Board of Directors (the “Board”) has declared monthly cash dividends for its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock (“Series A Preferred Stock”) and its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (“Series B Preferred Stock”) for July, August and September 2025.

SOMERSET, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, today announced the launch of its fully integrated, AI-driven dermatology EHR, designed to streamline clinical workflows and collections, while enhancing patient engagement and improving financial outcomes for dermatology practices.